european crypto coin Top stories

In the first 11 months of GEM, the scale of raising funds by issuing 34 new shares dropped significantly year-on-year. Statistics show that from January to November, 2024, there were 34 new shares listed on GEM, with a total amount of raised funds of about 20.174 billion yuan. The number of issues and the scale of raising funds decreased by about 67% and 83% respectively year-on-year, and the number of listed new shares declined for three consecutive years. Among them, Nova Nebula and Yilian Technology have raised a total of more than 1 billion yuan, which is on the top. The share prices of the first-time shares of GEM all rose on the first day of listing, among which Changlian Technology and Shangda Shares rose more than 1000% on the first day of listing. In addition, there are 17 new shares listed income increased by more than 200%. In terms of underwriters, in the first November of 2024, the number of main underwriting projects of CITIC Jiantou, Guotai Junan and CICC was in the top three. Judging from the scale of fundraising, the total number of projects underwritten by Minsheng Securities and CITIC Jiantou exceeds 2.5 billion yuan, and the project scale of China Merchants Securities, Huatai United Securities and Guotai Junan exceeds 1.5 billion yuan. (Xinhua Finance)Yingsi Intelligent announced that it had received a milestone payment of $10 million from Exelixis. On December 13th, Yingsi Intelligent, a biomedical technology company, announced that based on the progress made in the clinical stage of XL309(ISM3091) project, the company had recently received the first clinical milestone payment from Exelixis, with a total amount of $10 million.Onlikon: Compound α-keto acid tablets are planned to be selected for the tenth batch of national centralized drug procurement. Onlikon announced on December 13, and on December 12, the company participated in the bidding for the tenth batch of national centralized drug procurement organized by the National Drug Joint Procurement Office. After the bid opening and evaluation by the Joint Procurement Office, the company plans to select this centralized drug procurement. The indication of that medicine is to prevent and treat the damage caused by metabolic disorder in protein due to chronic renal insufficiency. The drug is a national medical insurance catalogue product, with an annual sales of 218,900 yuan in 2023, accounting for 0.01% of the company's annual operating income in 2023.

"Shanghai housing subsidy is 300,000 yuan" and "down payment is 20,000 yuan to buy 1.8 million hardcover existing houses"? Rumor has come. Recently, there have been a number of housing advertisements on the short video platform. The agent who released the housing claimed that he could receive the "housing subsidy" when buying a house in Shanghai, with the amount ranging from 200,000 yuan to 300,000 yuan. An intermediary declared: "Shanghai Songjiang New Town has a total price of 760,000 yuan and a housing subsidy of 250,000 yuan." "After receiving the subsidy, you can buy a 78-square-meter house with a down payment of 50,000 yuan." There is also an intermediary who claims: "The minimum payment can be only 20,000 yuan, and you can buy a finely decorated existing house with a total price of 1.8 million yuan." The reporter consulted a number of intermediaries and learned that the so-called "purchase subsidies" appearing in short videos are not government subsidies, but gimmicks. When the house-watchers consult subsidies on the spot, different intermediaries will have different calibers. Usually, there are three routines-one is to raise the price first and then lower the price. Second, the so-called "subsidy" is actually that developers lend money to buyers to pay down payment, and buyers have to pay interest. Third, the commission returned by the intermediary to the buyers is packaged as a "subsidy". (Shanghai rumor platform)Morgan Stanley called concerns about South Korean financial stocks "excessive". Morgan Stanley said that recent political developments have hit South Korean financial stocks particularly hard because people are worried that reform efforts may be delayed and the risk of tightening supervision.According to people familiar with the matter, Trump's advisers and officials from his newly formed government efficiency department asked him if he could abolish the Federal Deposit Insurance Corporation (FDIC).

CITIC Jiantou: The domestic cross-border e-commerce industrial chain has been gradually improved. CITIC Jiantou said that from 2010 to 2014, China's cross-border e-commerce entered a stage of rapid development. With the rise of mobile Internet infrastructure and the penetration rate of overseas cross-border e-commerce giants in the Mainland, the supporting facilities of the industrial chain have been gradually improved, subdivided and specialized, relevant policies have continued to exert their strength, and the customs supervision model has gradually become clear; Cross-border e-commerce industry chain is long, and there are relatively many hidden risk points because it involves cross-border. The cost structure of each link is mainly different due to the differences in participation roles, platform models, product types, warehousing and logistics structures, etc. Overall, the current cost structure is relatively stable, but there is also a large room for optimization. The degree of specialization and refinement of service providers will be improved, and the overall control, collaboration and empowerment of the industry chain and the refined arrangement led by big data and industry cognition will become one of the core competitiveness.The yield of 10-year active bonds in China inter-bank bond market initially dropped by more than 3 basis points to 1.775% and then hit a record low. The yield of 30-year active bonds in China inter-bank bond market initially dropped by nearly 4 basis points to 2%, also hitting a record low.Yingsi Intelligent announced that it had received a milestone payment of $10 million from Exelixis. On December 13th, Yingsi Intelligent, a biomedical technology company, announced that based on the progress made in the clinical stage of XL309(ISM3091) project, the company had recently received the first clinical milestone payment from Exelixis, with a total amount of $10 million.